Importance of lipid levels in elderly diabetic individuals - Baseline characteristics and 1-year - Survey of cardiovascular events

被引:7
作者
Hayashi, Toshio [1 ]
Kawashima, Seinosuke [2 ]
Itoh, Hideki [3 ]
Yamada, Nobuhiro [4 ]
Sone, Hirohito [5 ]
Watanabe, Hiroshi [6 ]
Hattori, Yoshiyuki [7 ]
Ohrui, Takashi [8 ]
Yoshizumi, Masashi [9 ]
Yokote, Koutaro [10 ]
Kubota, Kiyoshi [11 ]
Nomura, Hideki [12 ]
Umegaki, Hiroyuki [1 ]
Iguchi, Akihisa [1 ]
机构
[1] Nagoya Univ, Grad Sch Med, Dept Geriatr, Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc & Resp Med, Kobe, Hyogo, Japan
[3] Tokyo Metropolitan Geriatr Hosp, Tokyo 173, Japan
[4] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Internal Med Endocrinol & Metab, Tsukuba, Ibaraki 305, Japan
[5] Ochanomizu Univ, Dept Nutr, Tokyo, Japan
[6] Hamamatsu Univ Sch Med, Dept Clin Pharmacol & Therapeut, Hamamatsu, Shizuoka 43131, Japan
[7] Dokkyo Univ, Sch Med, Dept Endocrinol & Metab, Mibu, Tochigi 32102, Japan
[8] Tohoku Univ, Sch Med, Dept Geriatr Med, Sendai, Miyagi 980, Japan
[9] Hiroshima Univ, Grad Sch Biomed Sci, Dept Cardiovasc Physiol, Hiroshima, Japan
[10] Chiba Univ Hosp, Dept Internal Med, Div Endocrinol Diabet & Metab, Chiba, Japan
[11] Univ Tokyo, Fac Med, Dept Pharmacoepidemiol, Tokyo, Japan
[12] Nagoya Kita Hosp, Dept Geriatr, Nagoya, Aichi, Japan
关键词
diabetes mellitus; elderly; HDL-cholesterol; ischemic heart disease; LDL-cholesterol;
D O I
10.1253/circj.72.218
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The respective incidences of ischemic heart and cerebrovascular disease (IHD, CVD) are high in diabetic individuals. Complications of dyslipidemia increase the risk, but direct evidence is limited, so a cohort prospective study (Japan-CDM) was conducted. Methods and Results The study group comprised 4,014 subjects with type 2 diabetes (1,936 women, 2,078 men; mean age 67.4 +/- 9.5 years) who were divided into dyslipidemic patients (79.1%) with or without medication (medicated, 50.9%; not medicated, 28.2%) and normo-lipidemic patients (20.9%). The incidence of IHD, CVD, arteriosclerosis obliterans (ASO), congestive heart failure (CHF) and death was assessed. IHD and CVD occurred in 0.82 and 0.67%, respectively, during the first year following registration. CHF, ASO and sudden death occurred in 0.27%, 0.12% and 0.12%, respectively. There was a significant statistical difference in the relation of elevated levels of high-density lipoprotein-cholesterol to lower rates of IHD and CVD. IHD and CVD in males were dependent on the level of low-density lipoprotein-cholesterol (LDL-C): 0.45%, 1.56%, 1.78%, 1.91% and 2.34% were observed in less than 2.11, 2.11 - 2.62, 2.63 - 3.15, 3.16 - 3.67, and more than 3.68 mol/L of LDL-C. In the lowest LDL-C group, death other than from vascular diseases was increased. Age, sex (male) and complicated hypertension increased the risk of events. Patients who were prescribed anti hyperlipidemic agents suffered less events than patients who were not being treated, which suggests direct effects of therapy. Conclusion Strict lipid control may be effective for reducing the incidence of vascular events in Japanese diabetic individuals.
引用
收藏
页码:218 / 225
页数:8
相关论文
共 29 条
[1]   Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT) [J].
Akisaki, Taichi ;
Sakurai, Takashi ;
Takata, Toshihiro ;
Umegaki, Hiroyuki ;
Araki, Atsushi ;
Mizuno, Sachiko ;
Tanaka, Shiro ;
Ohashi, Yasuo ;
Iguchi, Akihisa ;
Yokono, Koichi ;
Ito, Hideki .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2006, 22 (05) :376-384
[2]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[3]   Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS) [J].
Colhoun, HM ;
Betteridge, DJ ;
Durrington, PN ;
Hitman, GA ;
Neil, HAW ;
Livingstone, SJ ;
Thomason, MJ ;
Fuller, JH .
DIABETOLOGIA, 2005, 48 (12) :2482-2485
[4]  
Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3
[5]   Trends in cardiovascular complications of diabetes [J].
Fox, CS ;
Coady, S ;
Sorlie, PD ;
Levy, D ;
Meigs, JB ;
D'Agostino, RB ;
Wilson, PWF ;
Savage, PJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (20) :2495-2499
[6]   Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes [J].
Gaede, P ;
Vedel, P ;
Larsen, N ;
Jensen, GVH ;
Parving, H ;
Pedersen, O .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (05) :383-393
[7]  
Gavin JR, 1997, DIABETES CARE, V20, P1183
[8]  
GOTTO AM, 2002, AM J MED S8A, V112, P19, DOI DOI 10.1016/S0002-9343(02)01086-0
[9]  
Hata Yoshiya, 2002, J Atheroscler Thromb, V9, P1
[10]  
*IDS CLIN GUID TAS, 2006, DIABETIC MED, V23, P579